More than 1,000,000 patients are being treated with Dupixent globally. 1 Dupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration agreement. To date, dupilumab has ...

Powerbox Energy Systems, a homegrown clean energy company, has been making waves with its cutting-edge technology, innovative solutions, and commitment to sustainability. This article explores the ...

and Sanofi today presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational use of Dupixent ® (dupilumab) in adults with moderate-to-severe bullous ...

Lebrikizumab improves itch, sleep interference, and skin pain in atopic dermatitis patients previously treated with dupilumab, offering a new treatment option. A new Phase-3b study has found that ...

Please provide your email address to receive an email when new articles are posted on . Dupilumab was able to improve lichenification among patients aged 6 to 88 years with atopic dermatitis.

Perspective from John Luo, MD Patients with dupilumab prescriptions for their atopic dermatitis had lower risks for psychiatric and sleep disorders than those prescribed other treatments ...

They include Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab) and AZ's own IL-5 inhibitor Fasenra (benralizumab), which competes with GlaxoSmithKline's Nucala (mepolizumab) and Teva's ...

The United Nations’ top official for the Middle East warned Tuesday that the window may be closing on the possibility of achieving a two-state solution for Israelis and Palestinians.

EA FC 25 Road to the Final Player Pick SBC Cheapest Solution The Victor Boniface RTTF card has incredible attributes, with 89 pace, 92 shooting, 83 passing, 90 dribbling, 50 defending ...